Presentation is loading. Please wait.

Presentation is loading. Please wait.

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.

Similar presentations


Presentation on theme: "Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical."— Presentation transcript:

1 Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical Microbiology and Infection  Volume 9, Issue 9, Pages (September 2003) DOI: /j x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

2 Figure 1 Cumulative percentage inhibition of multi-drug-resistant isolates of Pseudomonas aeruginosa from ICUs (n = 57). Clinical Microbiology and Infection 2003 9, DOI: ( /j x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

3 Figure 2 Cumulative percentage inhibition of non-multidrug resistant isolates of P. aeruginosa from ICUs (n = 998). Clinical Microbiology and Infection 2003 9, DOI: ( /j x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical."

Similar presentations


Ads by Google